• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
98% Bifida Ferment Lysate
rhSOD (cosmetic grade)
Recombinant humanized collagen
Recombinant Humanized Small-molecule Collagen
Recombinant Humanized Small-molecule Collagen Solution
rhSOD

Marksons Pharma voluntarily recalls a batch of Metformin XR tablets

expresspharmaJune 09, 2020

Tag: Marksons Pharma , metformin , NDMA

Marksans Pharma has issued a voluntary recall of one batch of Metformin Extended-Release Tablets USP 500 mg (11279 bottles, Lot No. XP9004), informed the company through a statement.

It is due to the detection of NDMA as a matter of abundant precaution.

Metformin Extended-Release Tablets USP500 mg is indicated as an adjunct to diet and exercise to improve blood glucose control in adults with type 2 diabetes mellitus.


Previous:Gland Pharma launches of the first non-frozen ready-to-use Bivalirudin

Next:US FDA grants Lupin’s Mexiletine Orphan Drug Designation

Related News

Prenetics' IM8 Announces Collaboration with Mayo Clinic to Develop New Line of Premium Supplements

PRNewswireDecember 19, 2024

A New Premium Supplements Brand, Launched Officially on November 18th on IM8health.com

PeproMene Bio, Inc. and the Institute for Follicular Lymphoma Innovation Announce $11M Investment to Advance PMB-CT01 (BAFF-R CAR T cell therapy) for Relapsed/Refractory Follicular Lymphoma

PRNewswireDecember 19, 2024

Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration

PRNewswireDecember 20, 2024

Marksons Pharma voluntarily recalls a batch of Metformin XR tablets | Pharmasources.com

Corvia Medical Achieves CE Certification for Atrial Shunt Under New EU MDR Standards

PRNewswireDecember 21, 2024

Corvia Medical, Inc.announced today that it has achieved CE certification for the Corvia® Atrial Shunt System under the latest EU Medical Device Regulations (EU MDR 2017/745).

You may like
More>>

Metformin Hydrochloride and Glipizide Tablets

Metformin Hydrochloride and Glipizide Tablets
Dapagliflozin + Metformin

Dapagliflozin + Metformin
Metformin

Metformin
98.5% up, EP/USP/BP Metformin Hydrochloride 1115-70-4

98.5% up, EP/USP/BP Metformin Hydrochloride 1115-70-4
Metformin Hydrochloride Sustained- release Tablets

Metformin Hydrochloride Sustained- release Tablets
Metformin hcl

Metformin hcl
Metformin hydrochloride tablet 500mg,850mg, 1000mg

Metformin hydrochloride tablet 500mg,850mg, 1000mg
PU/polyurethane handmade sandwich panels

PU/polyurethane handmade sandwich panels
Metformin Hydrochloride

Metformin Hydrochloride
Metformin hydrochloride

Metformin hydrochloride

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service